How HLA-DM affects the peptide repertoire bound to HLA-DR molecules
- PMID: 9297535
- DOI: 10.1016/s0198-8859(97)00077-3
How HLA-DM affects the peptide repertoire bound to HLA-DR molecules
Abstract
Considerable progress has been made in the field of major histocompatibility complex (MHC) class II-restricted antigen presentation. The analysis of mutant cell lines defective in antigen presentation revealed a central role for the nonclassical MHC class II molecule HLA-DM. Cell biological and biochemical characterization of HLA-DM provided deeper insight into the molecular mechanisms underlying the loading process: HLA-DM accumulates in acidic compartments, where it stabilizes classical class II molecules until a high-stability ligand occupies the class II peptide binding groove. Thus, HLA-DM prevents empty alpha beta dimers from functional inactivation at low endosomal/lysosomal pH in a chaperone-like fashion. In the presence of peptide ligands, HLA-DM acts as a catalyst for peptide loading by releasing CLIP, the residual invariant chain-derived fragment by which the invariant chain is associated with the class II molecules during transport from the endoplasmic reticulum to the loading compartments. Finally, there is accumulating evidence that HLA-DM functions as a peptide editor that removes low-stability ligands, thereby skewing the class II peptide repertoire toward high-stability alpha beta: peptide complexes presentable to T cells.
Similar articles
-
Selection of the MHC class II-associated peptide repertoire by HLA-DM.Immunol Res. 1997;16(3):261-72. doi: 10.1007/BF02786394. Immunol Res. 1997. PMID: 9379076 Review.
-
HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion.Immunol Lett. 1997 Jun 1;57(1-3):209-11. doi: 10.1016/s0165-2478(97)00061-8. Immunol Lett. 1997. PMID: 9232453
-
Editing of the HLA-DR-peptide repertoire by HLA-DM.EMBO J. 1996 Nov 15;15(22):6144-54. EMBO J. 1996. PMID: 8947036 Free PMC article.
-
HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH.Immunity. 1997 Mar;6(3):293-302. doi: 10.1016/s1074-7613(00)80332-5. Immunity. 1997. PMID: 9075930
-
The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.Immunol Rev. 1999 Dec;172:267-78. doi: 10.1111/j.1600-065x.1999.tb01371.x. Immunol Rev. 1999. PMID: 10631952 Review.
Cited by
-
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.Ann Rheum Dis. 2005 Dec;64(12):1671-6. doi: 10.1136/ard.2005.038448. Epub 2005 May 26. Ann Rheum Dis. 2005. PMID: 15919676 Free PMC article. Review.
-
Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.Drug Saf. 2000 Dec;23(6):483-507. doi: 10.2165/00002018-200023060-00002. Drug Saf. 2000. PMID: 11144658 Review.
-
Association of HLA-DM polymorphism with the production of antiphospholipid antibodies.Ann Rheum Dis. 2004 Dec;63(12):1645-8. doi: 10.1136/ard.2003.015552. Ann Rheum Dis. 2004. PMID: 15547089 Free PMC article.
-
Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339.PLoS One. 2012;7(10):e47585. doi: 10.1371/journal.pone.0047585. Epub 2012 Oct 23. PLoS One. 2012. PMID: 23110081 Free PMC article.
-
Understanding the focused CD4 T cell response to antigen and pathogenic organisms.Immunol Res. 2009 Dec;45(2-3):123-43. doi: 10.1007/s12026-009-8095-8. Epub 2009 Feb 7. Immunol Res. 2009. PMID: 19198764 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
